BENZODIAZEPINE - ANVISA Registration 10071770904

Access comprehensive regulatory information for BENZODIAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10071770904 and manufactured by INNOVACON, INC.. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including MICROGENICS CORPORATION, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.